Live News EQUITY M impact May 28, 2026, 01:22 PM UTC

Novo Nordisk GLP-1 sales diverge

Novo Nordisk's oral GLP-1 sales patterns differ from injectables, impacting revenue. This may affect the company's market share in the diabetes treatment space.

NVO

SquawkNews Newsroom

Novo Nordisk's oral GLP-1 sales patterns differ from injectables, impacting revenue.

This may affect the company's market share in the diabetes treatment space.